The US Food and Drug Administration (FDA) announced on its Twitter account that it will temporarily allow Juul e-cigarette products to remain on the American market.
On the morning of July 6th, at 7:53 AM US time, the FDA announced on Twitter that it has temporarily suspended the marketing denial order against Juul. According to the FDA, "on July 5th, 2022, the FDA administratively paused the marketing denial order due to unique scientific issues in Juul's application, requiring additional review." The FDA stated that the marketing denial order against Juul will be temporarily suspended during the additional review period, but will not be revoked.
The FDA has stated on Twitter that all electronic nicotine delivery systems (ENDS) or products, including those made by Juul, are required by law to obtain FDA authorization in order to be sold legally. During the suspension or review period, authorization for marketing, sales, or transportation of Juul products is not implied.
In June, the FDA ordered Juul to stop marketing all of its e-cigarette products in the U.S., citing a lack of evidence regarding their safety. However, Juul was granted a temporary stay by a federal appeals court, and has requested an extension to the ban during the appeals process.
This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.
